The agreement was extended an additional three years and is valued in the mid-six figures. This pharmaceutical company is said to be yet another customer that has demonstrated its commitment to I-many and its comprehensive contract management solution.
John Rade, president and CEO of I-many, said: “New business demonstrates that we can compete and win against others in our markets. Contract extensions demonstrate customer loyalty and shows existing customers are satisfied with our services and products.”